ALLG Summit: Research and Clinical Care Priorities

 In News

On the 16 November 2016 the ALLG participated in a summit with 14 fellow blood cancer research and not for profit organisations to explore areas of potential future collaboration.

The meeting was facilitated by Professor Andrew Roberts, Head of Clinical Translation, Walter and Eliza Hall Institute. Three emerging priority areas identified through discussion:

  1. Improving care for regional, rural and remote communities
  2. Access to new drugs
  3. Support for research

ALLG is a For Purpose organisation; to deliver clinical trials to improve the outcomes of patients with blood cancer; to develop clinical trials that benefit the members and their research priorities; to partner with others that share our vision. In essence, we are a professional clinician-based organisation that seeks to improve care for patients with blood cancers through clinical trials.

The ALLG seeks to address the 3 common priority areas through achieving specific outcomes aligned to our strategic plan.

IMPROVING CARE FOR REGIONAL, RURAL AND REMOTE COMMUNITIES

wdt_ID Current Plans Planned Actions/Approaches to Achieve Outcome Seeking Partners Y/N

ACCESS TO NEW TREATMENT/NEW DRUGS

wdt_ID Current Plans Planned Actions/Approaches to Achieve Outcome Seeking Partners Y/N

Helping the ALLG:

Helping the ALLG is helping doctors and researchers to provide better treatments for patients, creating better lives.

Driven by this purpose, we are committed to providing our members with:

wdt_ID Blood cancer specialists need ALLG is committed to providing